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Abstract
Introduction: The purpose of this study was to examine the effect of payer
status on indicators of the quality of diabetes care delivered in four health care
systems that participated in a REACH Coalition’s efforts to eliminate health care
disparities for African Americans with diabetes.
Design and Methods: Secondary analyses of data from 899 health care records
of people who received diabetes care were conducted to determine differences in

quality of care by payer status. Extracted information included process
information related to frequency of A1C, lipid, and kidney tests, foot
examinations, and blood pressure measurements, as well as intermediate health
outcomes for blood pressure control, A1C results, lipid results, and kidney tests.
Multivariate logistic regression, which included variables that had a change >10%
for any payer status (based on odds ratio), was used to predict the likelihood of a
person with diabetes receiving a care measure and/or achieving desired health
outcomes related to diabetes control.
Results: There were no significant differences observed except: (1) LDL
cholesterol control where Medicare enrollees and Medicaid recipients
experienced poorer outcomes than those with commercial insurance (p = 0.04 for
both); and (2) foot exams where Medicaid recipients received fewer annual
exams than those with no insurance (p = 0.034).
Conclusions: Payer status had little effect on quality of diabetes care among this
population. Other influences not accounted for in this study apparently have a
great impact on quality of care in these four health systems.
Keywords: Diabetes, Health Insurance, Health care, Diabetes Outcomes,
Quality Care
The Effect of Payer Status on the Quality of Diabetes Care: Results from a
REACH 2010 Project
Diabetes mellitus (DM) is a growing public health epidemic. Approximately 23.6
million Americans have diabetes, and this number will likely double by 2050. 1
Previous large studies2,3 have identified methods to prevent or delay
development of diabetes and its complications. Several national organizations
and federal agencies such as the Centers for Medicare and Medicaid (CMS),
American Diabetes Association (ADA), and National Committee for Quality
Assurance (NCQA), have focused on improving the quality of care for people
living with diabetes4-7 and have identified and widely disseminated evidencedbased guidelines for the management of diabetes. Current practices, however,
remain suboptimal, and disparities in diabetes care are common.8-11
REACH 2010: Charleston and Georgetown Diabetes Coalition (REACH) is a
demonstration project funded by the Centers for Disease Control and Prevention.
Formed in 1999 as a broad-based, community-driven coalition incorporating the
principles of community-based participatory research, the coalition focuses on
improving health for African Americans (AfA) living with diabetes in Charleston
and Georgetown Counties.
Literature Review and Background
Many people with diabetes lack necessary resources for adequate health care.
An estimated 47 million Americans are without health insurance costing the US
public more than 130 billion dollars annually.12 Uninsured adults are greater than

three times more likely to lack a regular source of health care resulting in poor
continuity; thus, many have reported that the uninsured are far less likely to
receive evidence based care. For example, uninsured persons with diabetes
have been shown to receive significantly fewer preventive measures deemed
essential for quality diabetes care by the ADA.12-17
Health related outcomes are highly influenced by health care access and use,
which have been shown to be greatest among those with any healthcare payer
compared to those without any third party payer. The quality of health care is
influenced by complicated payment systems, multiple payment types, and use of
reimbursement as either incentives or disincentives.18-24 Based on the theoretical
framework presented in his book “The theory of demand for health insurance”,
John A. Nyman theorizes that consumers purchase health insurance so that they
can purchase high-value care when they become ill. They pay a premium in
exchange for health care when needed. Private health insurance and Medicare
Part B (covering 80% of customary costs of physician services, diabetes care,
supplies and education) fall into the consumer purchased health insurance, while
Medicaid falls into a government funded health insurance for specific groups of
those unable to pay. Those who have no private or government funded health
insurance usually bare the full cost of their care when ill or free or sliding scale
costs are based on the health care facility’s policies and abilities to provide
care.25
The effects of payer status have been shown to independently influence diabetes
care and outcomes,14,24 but little research has been done to examine the effect
that different payer types may have on diabetes care and outcomes.
Furthermore, no studies were identified that included data for South Carolina, a
state that has a disproportionate percentage of the population affected by
diabetes.
The purpose of this study was to examine the effect of payer status on indicators
of the quality of diabetes care delivered in four health care systems (two federally
qualified health centers, a primary care center in the community, and an
academic medical center specialty clinic) that participated in REACH Charleston
and Georgetown Diabetes Coalition (REACH) efforts to eliminate health care
disparities for African Americans with diabetes. REACH is a demonstration
project funded by the Centers for Disease Control and Prevention. Formed in
1999 as a broad-based, community-driven coalition incorporating the principles
of community-based participatory research, the coalition focuses on improving
health for African Americans (AfA) living with diabetes in Charleston and
Georgetown Counties.
The null hypotheses of this study were: There are no differences in the quality of
care for diabetes between/among:
Medicare enrollees compared to commercial insurance enrollees.

Medicaid recipients compared to commercial insurance enrollees.
Medicare enrollees and those with no insurance.
Medicaid recipients and those with no insurance.
Those with no insurance compared to commercial insurance enrollees.
Those with Medicaid compared to those with Medicare.
Methods
This quantitative, non-experimental study used a retrospective, cross-sectional
secondary analysis of REACH health record audit data to assess the quality of
care received by persons with diabetes in two counties in South Carolina during
the years 2001 to 2003. First, we present a brief overview of the methods for the
collection of the original data, and then discuss the methods for this secondary
analysis (current study design). Both studies were approved by the Institutional
Review Board for Human Research at the Medical University of South Carolina.
The primary dependent variables to determine quality of care based on payer
status were annual A1C and lipid testing, foot exams (≤1 or ≥2 per year), LDL-C
value (≤100 mg/dl; >130 mg/dl), A1C value (>9.0%; ≤7.0%) blood pressure
control (≤130/80 mm Hg), and microalbumin results (+ or -). The primary
independent variables were Medicare, Medicaid, commercial insurance, and no
third party payer. Covariates identified through the literature review and previous
REACH data analyses included age, race, gender, and clinic or health system
site.
Data Collection: Data were collected from a randomly selected list of all patients
with diabetes served by four different health systems: two federally qualified
health centers, a primary care center in the community, and an academic
medical center specialty clinic. Inclusion criteria were: adult ≥18 years, diagnosis
of diabetes prior to study year, ≥1 visit to health provider within study year.
Exclusion criteria were: prisoner, documented pregnancy, non-community
dwelling (ex. nursing home), or terminal illness (ex. hospice referral). Mitchell’s
sample size calculator was used to determine the number of subjects needed
from each clinical site. The total needed for each site was then divided into the
total number of patients actively managed at each site, and random selection
was made based on a table of random numbers.
Data were entered into Microsoft Access via laptop computers using a REACH
data collection instrument. Utilizing a 15 month collection timeframe allowed
documentation of patient’s annual care and time for providers to document
results of tests ordered throughout the previous year, and approximately three
months into the following year (to allow for appointments slightly beyond the 12
month period for annual tests). Data collection was completed by trained
abstractors. A reviewer independently re-abstracted a randomly selected sample
(10% of total from each site) of medical records and compared the data to initial
abstraction and all differences were resolved by concensus; average interrater

reliability on all categorical variables was high (96%) as assessed by the Kappa
statistic.
In this secondary analysis, data for the study were generated by the REACH data
analyst from all de-identified patients’ records in the REACH database. The data
set was electronically transferred into SPSS. No personal identifiers were
attached to the data set. Data for years 2001, 2002, and 2003 were combined
into one data set. Power calculations for this study used SPSS PowerSample 12.
With a total of 899 subjects, this study could detect a difference of 6% with a
power of 80% and α of 0.5.
Variables: Variables used to measure quality of care in the settings included
both using process measures (A1C testing, lipid testing, and number of foot
examinations) and intermediate outcomes measures (A1C results, LDL-C results,
kidney test results [microalbumin], and last recorded BP results). These
indicators of quality were chosen based on definitions provided by the Diabetes
Quality Improvement Project (DQIP),4 4 Health Effectiveness Data and
Information Set (HEDIS),26 the Foundation for Accountability, and accepted
standards of diabetes care from the ADA. Data from both the process and the
intermediate outcome measures were analyzed first as a composite score for all
subjects and then stratified by payer type for each quality measure. The data
were then further disaggregated by demographic variables (age, race, gender,
and clinic site) where categories provided sufficient sample size.
Data Analysis: Continuous demographic data (age) were analyzed using
ANOVA for differences between groups. Data analyses on categorical
demographics (race, sex, clinic site), as well as the proportion of patients
receiving diabetes care measures (diabetes related testing and results), were
completed using the χ2 statistical test. To assess if payer status was
independently associated with the likelihood of receiving quality diabetes care for
each indicator collectively and individually, multivariate logistic regression
analysis was performed with a focus on the variable for payer type.
Absolute percentages and proportions for each measure are reported as the
percent of patients receiving recommended care. Absolute measures for each
independent health care payer type and by health care facility are also reported.
Disaggregating by payer type, gender, race, and age where appropriate was
completed for each variable. Appropriateness for inclusion of all demographic
variables (with exception of continuous data, i.e. age) was completed using
stratification and non-stratification methods. An odds ratio (OR) or the probability
of occurrence over the probability of non-occurrence for obtaining selected health
care services or outcomes was provided for each measure of quality for each
individual payer source. The OR represented the probability of an individual
receiving quality diabetes care.

Potential confounders were evaluated to determine which covariates were to be
included in these analyses. Possible covariates identified in the literature
included race, gender, age, payer source, income, geographical location of care,
comorbid conditions, and clinic setting.26,27 Variables whose addition changed the
OR for diabetes care >10% were included in the models used to test the
hypotheses of this study.29
Statistical Analyses
Multivariate logistic regression models were completed for each of the five
hypotheses in exactly the same manner; only the payer focus in each of the
regression models changed to reflect comparisons between groups by payer
status.
The statistical analyses of the data were examined first by demographics and
process measures and intermediate outcomes by payer status. Covariates were
then determined by literature search and knowledge of the most frequent
comorbidities within this population. After inclusion of the selected covariates,
multivariate logistic regression models were completed to determine the
likelihood (OR) of an individual receiving process measures and achieving the
desired intermediate outcomes related to diabetes. The likelihood of receiving a
process of care measure or attaining the desired intermediate outcome was
represented by an OR of the dependent variable (process measures and
intermediate outcomes) given the influence of the independent variable and the
effects of the selected covariates.
Results
There were a total of 899 records included in the study, representing about 34%
Medicare, 32% with no insurance recorded, 24% with commercial insurance and
10% with Medicaid. Approximately 62% were female and 27% were males, and
11% did not identify gender (table 1).
Results of the multivariate logistic regression model to determine the OR for
receiving each of the quality of care measures are displayed in table 2. The first
number represents the adjusted OR for receiving measures of care or obtaining
recommended levels of test results. The adjusted OR is followed by the 95% CI
and the final column is the p-value for significance.
Null Hypothesis 1: For the intermediate outcome measures, Medicare enrollees
were 2.0 time more likely to have an LDL-C >130 mg/dl than those with
commercial insurance (p=0.04) (table 2). There were no significant differences in
the process measures for quality of diabetes care for Medicare enrollees when
compared to those with commercial insurance.

Null Hypothesis 2: For outcome measures, Medicaid enrollees were 1.8 times
more likely to have an LDL-C > 130 mg/dl than those with commercial insurance
(p=0.04) (table 2). There were no significant differences in the process of care
measures for quality diabetes care for Medicaid recipients when compared to
those with commercial insurance.
Null Hypothesis 3: There are no differences in either process of care measures
or outcome measure when assessing the quality of diabetes care for Medicare
enrollees when compared to those with no insurance (table 2).
Null Hypothesis 4: For process measures used to assess the quality of diabetes
care, those with no insurance were 1.6 times more likely to have the
recommended ≥2 annual foot examinations than Medicaid enrollees (p=0.03)
(table 2).There are no differences found among process of care measures for the
quality of diabetes care for Medicaid recipients when compared to those with no
insurance.
Null Hypothesis 5: There were no differences found in either process of care
measures or outcome measures used to assess the quality of diabetes care
among those with no insurance when compared to those with commercial
insurance (table 2).
Null Hypothesis 6: There were no differences in process of care or outcome
measure used in this study to assess the quality of diabetes care for Medicaid
recipients when compared to Medicare enrollees (table 2).
Summary of findings: When accounting for race, gender, age, type of
diabetes, type of clinic where care was received, geography, and co-morbidities
of care, this study found few differences in the quality of diabetes care based on
payer status. Among the process of care measures, when compared to those
with commercial insurance or those with no insurance provider, Medicaid
enrollees were significantly less likely to receive ≥2 foot examinations annually (p
= 0.03). For outcome measures, Medicare (p = 0.04) and Medicaid (p = 0.04)
enrollees were more than twice as likely to have an LDL-C level of >130 mg/dl
when compared to those with commercial or no insurance.

Discussion
The findings of this study are not consistent with other published findings that
found payer status had greater influences on the quality of diabetes care and
outcomes.14-17,28,30 Among the subjects in this study, regardless of payer status,
those having fewer apparent resources were found to receive equal quality of
care. Care was taken to account for potential extraneous variables in each of the
regression models. Thus, it is plausible that additional avenues of support other
than payer status exist for the persons in this study.

Applying Nyman’s theory of demand for health insurance,25 private insurance and
Medicare Part B were purchased by individuals to access high-value care and
could assist the individuals in accessing higher quality care for diabetes when
needed. However, the government sponsored Medicaid and the government
supported care in state supported academic institutions (academic health
centers) and the HRSA supported community health centers may also have
contributed to quality care. And when care guidelines are established by national
organizations and widely promulgated at local, state and national levels, we
theorize quality of diabetes care improved for all.25
Although the findings of significant differences by payer were few (Medicaid
enrollees less likely to receive foot exams and Medicare and Medicaid enrollees
less likely to have controlled LDL-C), they are serious. People with diabetes
experience higher rates of cardiovascular events such as strokes, heart failure,
vascular disease and myocardial infarctions and as many as 80% of persons with
diabetes will die as a result of coronary and vascular diseases.11 Even small
improvements in A1C and lipid controls can significantly reduce these
morbidities.
This study was designed to detect differences in lipid control among different
payer sources through carefully constructed multiple regression modeling.
However, there are some potential explanations not accounted for in the
regression models utilized such as adherence to the providers’
recommendations, diet, and exercise. Although REACH does not have a direct
measure of adherence to medical therapy, 70% of all Medicare enrollees in this
study had at least one annual lipid test ordered and completed. This is well
above the national averages of 31-56%.
Exercise and diet are known to improve lipid control. Within the population for
this study, Medicaid recipients and Medicare enrollees were significantly older
(average 8 years) than those with commercial insurance. Adults with Medicaid
self-reported fewer days of physical activity than other groups. Information on
physical activity, however, was limited in the REACH database. Although
providers often mentioned self-reported activity, there were little data regarding
the intensity of such activities. Although infrequently recorded in the patient
records in broad terms, specific information on diet therapy was not available for
this study.
One major difference identified between this and previous studies, is we
collected data from health centers and clinical sites where REACH is actively
engaged in improving care for persons with diabetes. We postulate that the
impact of REACH within each of these sites may have influenced the quality
diabetes care provided to all individuals regardless of the payment structure.
Based on earlier reports of analyses of the data,31 significant improvements in
reducing racial disparities have occurred for both the insured and uninsured.

However, it should be noted that initial data collected “insurance” or “no
insurance” but did not collect type of insurance until 2001.
Since 1999, REACH, a nurse-led project, and its community-based coalition
partners, have been involved with each of the four affiliated healthcare sites, and
designed and implemented, in conjunction with each site, interventions aimed at
reducing disparities in diabetes care and outcomes. For example, over 150
nurses were trained to conduct diabetes related foot examinations at the time of
visit. This frees the provider to focus on other issues while assuring that each
patient received the recommended foot care.
REACH expands its efforts beyond the structure of the site of care by making
patients partners in their healthcare. Examples of patient directed quality of care
issues include “Gold Cards” which are cards patients carry to document
individual goals and outcomes as well as providing information on recommended
frequency of tests; on-site lay led diabetes classes; and courses on
client/provider communications in an effort to improve overall self-management
skills and knowledge among those with diabetes.
Conclusions and next steps
In summary, the conclusions of this study are not consistent with the findings of
other published studies. Among this population, few differences in the quality of
diabetes care by payer status were identified. It is likely that among this
population, factors other than payer status had a greater influence on the quality
of diabetes care than payer status. Whether these factors include provider
practice habits, patient compliance, or self-management skills cannot be
determined from this study.
Repetition of this study in similar populations with a larger sample size would
help to determine if current quality of care by payer differs in other communities,
as had previously been reported in earlier studies in the literature. Additionally,
testing each specific REACH intervention in other populations and states is
recommended to determine efficacy and effectiveness for improving care among
other populations. Our next steps are to explore further improvements in diabetes
control as evidenced by improved A1C, blood pressure and lipid outcomes.
Studies are also needed to evaluate the effect of provider teams designed to
provide quality medical care based on ADA guidelines, as well as comprehensive
disease management education to both the patient and the family caregivers.
Nurses are a crucial, but under-used component of this type team approach,
especially in primary care settings where most diabetes care takes place.
References

1. Center for Disease Control and Prevention (CDC). (2009). Diabetes:
disabling, deadly, and on the rise, National Centers for Disease Control
and Prevention. Retrieved July 12, 2009, from
http://www.cdc.gov/Features/dsDiabetesTrends/.
2. The Diabetes Control and Prevention Group. (1993). The effect of
intensive treatment of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes mellitus. New
England Journal of Medicine, 329(14), 977-986.
3. UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). The Lancet, 352(9131): 837-853.
4. McLaughlin, S. (2002). The Diabetes Quality Improvement Project.
Diabetes Spectrum, 13, 5-12.
5. Fleming, B., Greenfield, S., Engalau, M., Pogach, L., Clauser, S., &
Parrott, M. (2001). The diabetes quality improvement project: Moving
science into health policy to gain an edge on the diabetes epidemic.
Diabetes Care, 24(10): 1815-1820.
6. National Committee for Quality Assurance. (2008). Diabetes Quality
Improvement Project Initial Measure Set (Final Version), NCQA. Retrieved
July 12, 2009, from http://www.ncqa.org/.
7. National Diabetes Quality Improvement Alliance. (2004). National diabetes
Improvement alliance performance measurement set for adult diabetes.
Retrieved July 12, 2009, from http://nationaldiabetes alliance.org/.
8. Center for Disease Control and Prevention (CDC). (2002). PreventiveCare Practices Among Persons with Diabetes ---United States, 1995 and
2001. MMWR Weekly 51(43): 965-969.
9. Davis, K., Schoen, C., Doty, M., & Tenney, K. (2002). Medicare versus
private Insurance Rhetoric and reality. Health Affairs, Web Exclusive,
2002 Project Hope-The People to People Health Foundation,
Incorporated. Retrieved July 12, 2009 from
http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.311v1.pdf.
10. Stone TT, Longo DR, Phillips RL, Jr., Hewett JE, Riley SL. (2002). Health
care System and insurer support for smoking cessation guideline
implementation. Journal of Health Care Finance, Winter, 29(2): 78-86.
11. National Center for Chronic Disease Prevention and Health Promotion.
(2004). Data & Trends Diabetes Surveillance System: End-Stage Renal
Disease. Retrieved July 12, 2009, from http://www.cdc.gov/nccdphp/.
12. Institute of Medicine (IOM). (2005). Uninsurance Facts and Figures: The
uninsured are sicker and die sooner. Institute of Medicine of the National
Academies, Washington, DC, 2005. Retrieved July 12, 2009, from
http://www.iom.edu/Object.File/Master/17/748/0.pdf.
13. Institute of Medicine (IOM). (2005). Uninsurance Facts and Figures: The
uninsured are sicker and die sooner. Institute of Medicine of the National
Academies, Washington, DC, 2005. Retrieved July 12, 2009, from
http://www.iom.edu/Object.File/Master/17/748/0.pdf.

14. Nelson, K., Chapko, M., Reiber G., & Boyko E. (2005). Impact of health
insurance. The association between health insurance coverage and
diabetes care; data from the 2000 Behavioral Risk Factor Surveillance
System. Health Services Research, April, 40(2):361-72.
15. Pagán JA, & Puig A. (2005). Differences in access to health care services
between insured and uninsured adults with diabetes in Mexico. Diabetes
Care, Feb, 28(2):425-6.
16. Pagán, J., Puig, A, & Soldo, B. (2007). Health insurance coverage and the
use of preventive services by Mexican adults. Health Economics, 16(12),
1359-69.
17. Zhang JX, Huang ES, Drum ML, Kirchhoff AC, Schlichting JA, Schaefer
CT, et al., (2008). Insurance Status and Quality of Diabetes Care in
Community Health Centers. American Journal of Public Health, Sep 17.
[Epub ahead of print].
18. Sudano, J. Jr., & Baker, W. (2003). Intermittent Lack of Health Insurance
Coverage and Use of Preventive Services. American Journal of Public
Health, January, 93(1).
19. Aday LA, Lee ES, Spears B, Chung CW, Youssef A, Bloom B. (1993).
Health Insurance and utilization of medical care for children with special
health care needs. Medical Care, Nov, 31(11):1013-26.
20. Arnold, P, Schlenker, T. (1992). The impact of health care financing on
childhood immunization practices. Archives of Pediatric and Adolescent
Medicine, June, 146:728-732.
21. Baker, L, Hopkins, D, Dixon, R, Rideout, J, & Geppert, J. (2004). Do
health plans influence quality of care? International Journal of Quality
Health Care, 16(1): 19-30.
22. Leichter, S. (2002). Cost and Reimbursement as Determinants of the
Quality of Diabetes Care: Reimbursement Determinants. Clinical
Diabetes, 20(1): 43-44.
23. Leichter, S. (2003). Third Party Reimbursement: Now Comes the Really
Difficult Part. Clinical Diabetes, Oct. 1, 21: 181-82.
24. Zhang, J., Kirchhoff, A., Walk, J., and Chin, M. (2006). The Quality of
Diabetes Care by insurance Status in Community Health Centers. Paper
presented at the annual meeting of the Economics of Population Health:
Inaugural Conference of the American Society of Health Economists, TBA,
Madison, WI, USA. Oct. 05. Retrieved July 12, 2009, from
http://www.allacademic.com/meta/p90130_index.html.
25. Nyman, JA (2003). The theory of demand for health insurance. Palto Alto,
CA: Stanford University Press.
26. National Committee for Quality Assurance (2001). AMA, JCAHO AND
NCQA Release common measures for diabetes care. Retrieved July 12,
2009, from http://www.ncqa.org.
27. Chin, M., Zhang, J., & Merrell, K. (1998). Diabetes in the African-American
Medicare population: Morbidity, Quality of care, and resource utilization.
Diabetes Care, 21(7): 1090-05.

28. Schneider, E., Zaslavski, Al, & Epstein, A. (2002). Racial disparities in the
quality of care for enrollees in Medicare managed care. Journal of the
American Medical Association, 287: 1288-94.
29. Maldonado, G. & Greenland, S. (2003). Simulation study of confounderselection strategies. American journal of Epidemiology, 138(11): 923-36.
30. Zhang X, Geiss LS, Cheng YJ, Beckles GL, Gregg EW, Kahn HS. (2008).
The missed patient with diabetes: how access to health care affects the
detection of diabetes. Diabetes Care, Sep., 31(9):1748-53.
31. Jenkins, C., McNary, S., Carlson, B., King M.G., Hossler, C., Magwood,
G., et al., Reducing Disparities for African Americans with Diabetes:
Progress Made by the REACH 2010 Charleston and Georgetown
Diabetes Coalition. Public Health Reports, May-June, 119(3): 322-30.
Table 1
Sample Size by Race, Gender, and Payer Status for Chart Audit Data of
People with Diabetes seen in Health Systems Participating in REACH
Charleston and Georgetown Diabetes Coalition (2001-2003)
Payer Status

Sample by
Race and
Gender

Medicare Medicaid None Commercial Total
#

#

#

Insurance

#

(%)

(%)

(%)

#

(%)

(%)

African

181

66

134

72

453

American

(77)

(85)

(72)

(81)

(50.4)

African

55

12

52

17

136

American

(23)

(15)

(28)

(19)

(15.1)

Non-

27

4

20

58

109

Hispanic

(55)

(67)

(59)

(48)

(12.1)

Non-

22

2

14

64

102

Hispanic

(45)

(33)

(41)

(52)

(11.3)

female

male

White
female

White male

Race and

18

3

70

8

99

(3)

(24)

(4)

(11.0)

303

87

290

219

899

(34)

(10)

(32)

(24)

(100)a

Gender not (6)
documented
Total
a

Total is actually 99.9% but rounded to 100%

Table 2
Comparison of Process and Outcomes Measures Disaggregated by Payer Status
Process Measures
Payer Status Medicare vs.
Comm.
Statistical
OR CI
Sig.
Measures
A1C test ≥ 1 1.00 0.40,2.53 0.98
annually
A1C test ≥ 2 0.99 0.53,1.9 0.99
annually
AIC test ≥ 4 0.92 0.78,4.9 0.15
annually
Lipid test ≥ 1 0.81 0.31,2.1 0.81
annually
Foot exam ≥ 0.50 0.22,1.17 0.11
2 annually
B/P check ≥ 1 0.39 0.09,1.7 0.21
annually
Microalbumin 1.45 0.7,2.97 0.31
test ≥ 1
annually

Medicaid vs.
Medicare vs.
Uninsured vs. Uninsured vs. Medicaid vs.
Comm.
uninsured
Medicaid
Comm.
Medicare
OR CI Sig. OR CI
Sig. OR CI Sig. OR CI Sig. OR CI
Sig.
1.05 0.37, 0.92
2.97
1.4 0.71, 0.29
3.1
1.14 0.37, 0.81
0.54
1.18 0.38, 0.77
3.62
2.02 0.74, 0.17
5.54
0.41 0.08, 0.27
2.0
0.86 0.36, 0.75
2.1

0.93 0.7,
0.96 1.3 0.6, 0.51 0.9
11.79
2.8
0.9 0.53, 0.80 1.4 0.7, 0.36 1.1
1.6
2.7
0.96 0.4, 2.3 0.93 1.3 0.6, 0.50 1.1
2.8
0.79 0.3,1.99 0.62 0.66 0.3, 0.29 1.3
1.4
0.94 0.4, 2.0 0.87 1.62 1.0, 0.03c 1.0
2.7
0.63 0.1, 3.9 0.10 0.24 0.04, 0.10 1.5
1.3
0.84 0.4, 1.7 0.62 1.2 0.64, 0.55 1.2
2.3

Outcome Measures
Payer Status Medicare vs.
Medicaid vs.
Medicare vs.
Uninsured vs.
Comm.
Comm.
uninsured
Medicaid
Statistical
OR CI
Sig. OR CI Sig. OR CI
Sig. OR CI
Sig.
Measures
A1C ≤ 7.0% 0.68 0.37,1.2 0.22 1.3 0.6, 0.45 1.5 0.65, 0.34 0.64 0.37, 0.11
2.9
3.4
1.1
A1C > 9.0% 1.1 0.41,2.95 0.84 0.674 0.22, 0.48 0.70 0.3, 0.46 1.0 0.5, 0.83
2.06
1.8
2.4
LDL-C ≤ 100 0.61 0.4,1.0 0.69 0.48 0.2, 0.37 0.8 0.4, 0.60 0.9 0.5, 0.93
mg/dl
0.9
1.8
1.9
LDL-C > 130 2.0 0.66,4.47 0.04c 1.8 0.7, 0.04c 0.56 0.2, 0.23 1.3 0.56, 0.32
mg/dl
4.8
1.5
3.0
BP > 130/80 0.69 0.38,1.26 0.22 1.06 0.51, 0.87 1.1 0.6, 0.72 0.77 0.45, 0.33
mm Hg
2.2
2.0
1.3
Nephropathy 1.4 0.37,5.4 0.61 0.88 1.7, 0.88 0.45 0.09, 0.31 0.64 0.14, 0.57
4.5
2.1
3.0

0.28, 0.39 0.9
1.64
0.6, 0.8 1.2
2.0
0.43, 0.87 1.1
2.7
0.51, 0.59 1.1
3.2
0.47, 0.86 0.8
2.45
0.25, 0.62 0.1
9.97
0.6, 0.62 1.1
2.4

0.4,1.8 0.98
0.5,1.2 0.51
0.5,1.8 0.58
0.4,2.2 0.90
0.4,1.6 0.60
0.03,1.1 0.06
0.5,1.9 0.87

Uninsured vs. Medicaid vs.
Comm.
Medicare
OR CI Sig. OR CI
Sig.
1.0 0.5, 0.84 0.2
1.9
1.6 0.6, 0.33 0.9
4.2
0.7 0.42, 0.25 0.8
1.2
1.7 0.66, 0.26 1.0
4.5
0.9 0.5, 0.72 0.8
1.6
2.2 0.5, 0.31 0.9
10.2

0.1,1.5 0.46
0.5, 1.8 0.98
0.4,1.6 0.56
0.4,2.3 0.91
0.2,2.9 0.75
0.2,3.4 0.93

Comm. = Commercial Insurance
OR = Odds Ratio
CI = Confidence Interval (95%)
Significance at α 0.05

